Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

VLDL could be an early warning sign for male pattern baldness.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Tiny particles called extracellular vesicles show promise for skin improvement and anti-aging in facial care but face challenges like low production and lack of research.

Upadacitinib effectively treats severe alopecia areata and is safe.

New genetic discoveries in alopecia areata could lead to better treatments.

Stem cell-derived vesicles show promise for healing diabetic wounds.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Avicennia marina heartwood extract shows strong antioxidant potential for health benefits.

Rat hair-follicle stem cells can become heart cells with specific supplements.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

A new treatment for hair loss shows promise with fewer side effects.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.

New treatment using engineered nanovesicles in hydrogel improves hair growth by repairing hair follicle cells in a mouse model of hair loss.

Special cells can help regrow hair in alopecia areata.

Botulinum toxin type A injections improved hair growth and scalp health in a woman with radiation-induced hair loss.

Animal and mathematical models help understand and develop treatments for alopecia areata.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

A machine learning model can predict alopecia areata early using specific gene markers.

A COVID-19 vaccine may trigger severe hair loss in rare cases.

Cyclosporin A vesicles effectively regrow hair and reduce inflammation in alopecia areata.